Asaleo Care Ltd

AHY Details
·         Weak guidance:Asaleo Care Ltd (ASX: AHY) stock fell over 4.8% on March 23, 2017 as the group paid dividend. The group now expects a low single digit profit growth in FY17 as compared to the prior corresponding period. The group forecasts a free cash flow in the range of $85m to $95m given the program to optimize working capital levels and recycle capital into higher returning investments. The group’s underlying EBITDA lost 10% to $130.7 million while Personal Care EBITDA lost 7.1% yoy to $66.9 million during the period. The group’s Tissue EBITDA fell 13% to $63.8 million. AHY’s underlying NPAT reached $64.6 million, which is down 15.2% impacted by FX impact on costs and challenging trading environment.
 
·         Recommendation:AHY stock rallied over 17.7% in the last three months (as of March 22, 2017). We give a “Hold” recommendation on the stock at the current price of $ 1.58


Fiscal Year of 2016 Performance (Source: Company Reports) 

Alacer Gold Corp

AQG Details
·         Volatile commodity prices dragged the stock lower: Alacer Gold Corp (ASX: AQG) stock lost over 5.3% on March 23, 2017 due to commodity price volatility. The group reported that their Sulfide Project is advancing on time and on budget while the Initial Mineral Resource for Çöpler District confirms satellite oxides.The group also reported a Positive PFS released for Gediktepe demonstrating economically and technically viable project. On the other hand, AQG produced 119,036 gold ozs at total cash costs of $738/oz and AISC of $966/oz in 2016.
 
·         Recommendation: Given the trading scenario and volatile conditions, we give an “Expensive” recommendation on the stock at the current price of $ 2.70

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.